Access cutting-edge male pattern baldness treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access male pattern baldness specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related male pattern baldness treatment provided free
This study will evaluate the safety and efficacy of VDPHL01 in male subjects with Androgenetic Alopecia (AGA). AGA (or male pattern baldness) is a genetic disorder caused by an excessive (too much) hair follicle response to androgens (hormone) that causes hair loss. VDPHL01 8.5 mg Tablet is an investigational oral drug to treat male pattern baldness. This multi-center, double blind, study will last about 13 months and includes 11 study visits (screening, baseline (day 1), week 2, month 1, mont
Sponsor: Veradermics, Inc.
Check if you qualify for this male pattern baldness clinical trial in Phoenix, AZ
If you're searching for male pattern baldness treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced male pattern baldness specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.